Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5789)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 15, 2021 (publication date) through Sep 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li ZP, Liu JX, Lu LL, Wang LL, Xu L, Guo ZH, Dong QJ. Overgrowth of Lactobacillus in gastric cancer. World J Gastrointest Oncol 2021; 13(9): 1099-1108 [PMID: 34616515 DOI: 10.4251/wjgo.v13.i9.1099] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i9/1099.htm |
| Number | Citing Articles |
| 1 |
Farzaneh Fakharian, Behnoush Asgari, Ali Nabavi-Rad, Amir Sadeghi, Neda Soleimani, Abbas Yadegar, Mohammad Reza Zali. The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.953718
|
| 2 |
Linda J. Paul, Aaron C. Ericsson, Frank M. Andrews, Zachary McAdams, Michael L. Keowen, Michael P. St Blanc, Heidi E. Banse, Jan S. Suchodolski. Field study examining the mucosal microbiome in equine glandular gastric disease. PLOS ONE 2023; 18(12): e0295697 doi: 10.1371/journal.pone.0295697
|
| 3 |
Baptiste Oosterlinck, Hannah Ceuleers, Wout Arras, Joris G. De Man, Karen Geboes, Heiko De Schepper, Marc Peeters, Sarah Lebeer, Jurgita Skieceviciene, Georgina L. Hold, Juozas Kupcinskas, Alexander Link, Benedicte Y. De Winter, Annemieke Smet. Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer. Microbiome 2023; 11(1) doi: 10.1186/s40168-023-01534-w
|
| 4 |
Miseker Abate, Elvira Vos, Mithat Gonen, Yelena Y. Janjigian, Mark Schattner, Monika Laszkowska, Laura Tang, Steven B. Maron, Daniel G. Coit, Santosh Vardhana, Chad Vanderbilt, Vivian E. Strong. A Novel Microbiome Signature in Gastric Cancer. Annals of Surgery 2022; 276(4): 605 doi: 10.1097/SLA.0000000000005587
|
| 5 |
Marek Majewski, Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, Ewelina Grywalska, Kamil Torres. Microbiota and the Immune System—Actors in the Gastric Cancer Story. Cancers 2022; 14(15): 3832 doi: 10.3390/cancers14153832
|
| 6 |
Bingsen Wang, Jiahui Luan, Weidong Zhao, Junbao Yu, Anqing Li, Xinxin Li, Xiaoqin Zhong, Hongyun Cao, Ruicai Wang, Bo Liu, Shiyong Lu, Mei Shi. Comprehensive multiomics analysis of the signatures of gastric mucosal bacteria and plasma metabolites across different stomach microhabitats in the development of gastric cancer. Cellular Oncology 2024; doi: 10.1007/s13402-024-00965-3
|
| 7 |
Oulan Liao, Guanshui Ye, Qin Du, Jun Ye. Gastric microbiota in gastric cancer and precancerous stages: Mechanisms of carcinogenesis and clinical value. Helicobacter 2023; 28(3) doi: 10.1111/hel.12964
|
| 8 |
Xiangqun Xiao, Renling Zhang, Junhong Lu, Yifeng Xu, Zhujing Zhu, Yiqin Wang, Yaxiang Shi, Yiming Hao, Jian Zhang. Alterations of Microorganisms in Tongue Coating of Gastric Precancerous Lesion Patients with a Damp Phlegm Pattern. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/7210909
|
| 9 |
Tadashi Fujii, Teiji Kuzuya, Nobuhiro Kondo, Kohei Funasaka, Eizaburo Ohno, Yoshiki Hirooka, Takumi Tochio. Altered intestinal Streptococcus anginosus and 5α-reductase gene levels in patients with hepatocellular carcinoma and elevated Bacteroides stercoris in atezolizumab/bevacizumab non-responders.
Journal of Medical Microbiology
2024; 73(9) doi: 10.1099/jmm.0.001878
|
| 10 |
Priyankar Dey, Saumya Ray Chaudhuri. Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches. Biology 2022; 11(5): 757 doi: 10.3390/biology11050757
|
| 11 |
Wing Sum Shin, Fuda Xie, Bonan Chen, Jun Yu, Kwok Wai Lo, Gary M. K. Tse, Ka Fai To, Wei Kang. Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein-Barr Virus. Cancers 2023; 15(20): 4993 doi: 10.3390/cancers15204993
|
| 12 |
Tao Sun, Jun Liu, Zhen An. Exploring the correlation between gut microbiota and benign gastric tumors: A Mendelian randomization study. Medicine 2024; 103(32): e39247 doi: 10.1097/MD.0000000000039247
|
| 13 |
Priyankar Dey, Saumya Ray Chaudhuri. The opportunistic nature of gut commensal microbiota. Critical Reviews in Microbiology 2023; 49(6): 739 doi: 10.1080/1040841X.2022.2133987
|
| 14 |
Precious Mathebela, Botle Precious Damane, Thanyani Victor Mulaudzi, Zilungile Lynette Mkhize-Khwitshana, Guy Roger Gaudji, Zodwa Dlamini. Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer. International Journal of Molecular Sciences 2022; 23(22): 13750 doi: 10.3390/ijms232213750
|
| 15 |
Cátia Domingues, Cristiana Cabral, Ivana Jarak, Francisco Veiga, Marília Dourado, Ana Figueiras. The Debate between the Human Microbiota and Immune System in Treating Aerodigestive and Digestive Tract Cancers: A Review. Vaccines 2023; 11(3): 492 doi: 10.3390/vaccines11030492
|
| 16 |
Han-Na Kim, Min-Jeong Kim, Jonathan P. Jacobs, Hyo-Joon Yang. Altered Gastric Microbiota and Inflammatory Cytokine Responses in Patients with Helicobacter pylori-Negative Gastric Cancer. Nutrients 2022; 14(23): 4981 doi: 10.3390/nu14234981
|
| 17 |
Hyo-Joon Yang. Gastric Cancer and Gastric Microbiome. The Korean Journal of Gastroenterology 2023; 81(6): 235 doi: 10.4166/kjg.2023.055
|
| 18 |
Yiwen Wang, Wenjie Han, Na Wang, Mengzhen Han, Meng Ban, Jianying Dai, Yuesheng Dong, Tao Sun, Junnan Xu. The role of microbiota in the development and treatment of gastric cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1224669
|